LILRB4 might be vital in gatekeeping PD clinical characteristics by tuning nigrostriatal dopaminergic neuron function, AD‐related pathology, WM microstructural alteration, and astrocyte activation. This evidence concerns the gene LILRB4 and Alzheimer disease.